SANDERCOCK BRETT (Chief Financial Officer) received a stock award from RESMED INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/24/2025ACC: 0000943819-25-000171
Officer· Chief Financial Officer
Since Mar 2026
+2.71K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.71K acquired
Non-Derivative Transactions1
ResMed Common Stock
Direct
Shares
+2.71K
Price / share
—
Trade value
—
% of position
3.2%
11/20/2025
85.78K→88.50K
Total
Net shares
+2.71K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Direct | 11/20/2025 | A · Award | +2.71K | — | — | 3.2% | 85.78K | 88.50K |
| Total | +2.71K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported